Maria Pihlgren

USPTO Granted Patents = 17 (Patent Applications = 11)

CIPO Patents = 9

EPO Patents = 14 (Patent Applications = 12)

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 161(Granted Patents)

Location History:

St. Sulpice, CH (2011 - 2014)
Mont-sur-Lausan, CH (2017)
Mont-sur-Lausanne, CH (2014 - 2018)

Company Filing History:

Katholieke Universiteit Leuven

where one patent can have more than one assignee

Years Active: 2011-2018

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10100104 - Methods of diagnosing tau-protein-associated disease (2018-10-16),

2. 10066010 - Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau (2018-09-04),

3. 9657091 - Humanized tau antibody (2017-05-23),

4. 9598485 - Anti-tau antibodies and methods of use (2017-03-21),

5. 9585956 - Polynucleotides encoding anti-amyloid beta monoclonal antibodies (2017-03-07),

6. 9540434 - Phosphospecific antibodies recognising tau (2017-01-10),

7. 9403902 - Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody (2016-08-02),

8. 9304138 - Pharmaceutical composition (2016-04-05),

9. 9175094 - Monoclonal antibody (2015-11-03),

10. 9146244 - Polynucleotides encoding an anti-beta-amyloid monoclonal antibody (2015-09-29),

11. 8796439 - Nucleic acid molecules encoding a humanized antibody (2014-08-05),

12. 8647631 - Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines (2014-02-11),

13. 8613923 - Monoclonal antibody (2013-12-24),

14. 8246954 - Methods of treating amyloidosis with humanized anti-beta-amyloid antibodies (2012-08-21),

15. 8124353 - Methods of treating and monitoring disease with antibodies (2012-02-28),

Title: Maria Pihlgren: Innovator in Tau-Protein-Associated Disease Diagnostics

Introduction

Maria Pihlgren is a prominent inventor based in Mont-sur-Lausanne, Switzerland. She has made significant contributions to the field of medical diagnostics, particularly in relation to tau-protein-associated diseases. With a total of 17 patents to her name, her work focuses on innovative methods for diagnosing and treating conditions such as Alzheimer's Disease.

Latest Patents

Among her latest patents are groundbreaking methods for diagnosing tau-protein-associated diseases. One notable invention involves methods and compositions for therapeutic and diagnostic use in treating diseases caused by neurofibrillary tangles. This invention specifically relates to antibodies that recognize and bind to phosphorylated pathological protein tau-conformers. These antibodies are crucial for the therapeutic and diagnostic treatment of tauopathies, including Alzheimer's Disease. Another patent addresses similar methods of diagnosing diseases associated with neurofibrillary tangles using phosphospecific antibodies that recognize tau.

Career Highlights

Maria has worked with notable companies in the biotechnology sector, including Ac Immune SA and Genentech, Inc. Her experience in these organizations has allowed her to develop and refine her innovative approaches to medical diagnostics.

Collaborations

Throughout her career, Maria has collaborated with esteemed colleagues such as Andrea M. Pfeifer and Andreas Muhs. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Maria Pihlgren stands out as a leading inventor in the realm of tau-protein-associated disease diagnostics. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.